BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 36737790)

  • 1. Mesenchymal non-meningothelial tumors of the central nervous system: a literature review and diagnostic update of novelties and emerging entities.
    Tauziède-Espariat A; Hasty L; Métais A; Varlet P
    Acta Neuropathol Commun; 2023 Feb; 11(1):22. PubMed ID: 36737790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding the spectrum of "mesenchymal" tumors of the central nervous system.
    Pizzimenti C; Gianno F; Gessi M
    Pathologica; 2022 Dec; 114(6):455-464. PubMed ID: 36534424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mesenchymal and Non-meningothelial Tumors Involving the Central Nervous System].
    Oya S; Murakami C
    No Shinkei Geka; 2023 Sep; 51(5):837-844. PubMed ID: 37743335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracranial mesenchymal tumor with (novel) COX14::PTEN rearrangement.
    d'Amati A; Gianno F; Scuccimarri L; Lastilla M; Messina R; Signorelli F; Zimatore DS; Barresi S; Miele E; Alaggio R; Rossi S; Maiorano E; Ingravallo G; Giangaspero F; Antonelli M
    Acta Neuropathol Commun; 2023 Jun; 11(1):95. PubMed ID: 37312212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central nervous system tumors of uncertain differentiation.
    A Jacobo J
    World Neurosurg X; 2024 Apr; 22():100349. PubMed ID: 38455248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embryonal tumors in the WHO CNS5 classification: A Review.
    Gianno F; Miele E; Antonelli M; Giangaspero F
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S73-S82. PubMed ID: 35562137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sarcomas of the central nervous systems. Clinical observations].
    Ryzhova MV; Galstyan SA; Telysheva EN; Shaikhaev EG; Snigireva GP; Gorelyshev SK; Kadyrov SU; Shimanskiy VN; Shugay SV; Panina TN
    Arkh Patol; 2022; 84(3):40-47. PubMed ID: 35639842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary central nervous system sarcoma with DICER1 mutation-treatment results of a novel molecular entity in pediatric Peruvian patients.
    Diaz Coronado RY; Mynarek M; Koelsche C; Mora Alferez P; Casavilca Zambrano S; Wachtel Aptowitzer A; Sahm F; von Deimling A; Schüller U; Spohn M; Sturm D; Pfister SM; Morales La Madrid A; Sernaque Quintana R; Sarria Bardales G; Negreiros Chinchihuara T; Ojeda Medina L; Garcia-Corrochano Medina P; Campos Sanchez DA; Ponce Farfan J; Rutkowski S; Garcia Leon JL
    Cancer; 2022 Feb; 128(4):697-707. PubMed ID: 34674226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal, non-meningothelial tumors of the central nervous system.
    Jellinger K; Paulus W
    Brain Pathol; 1991 Jan; 1(2):79-87. PubMed ID: 1669699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel SMARCA2-CREM fusion: expanding the molecular spectrum of intracranial mesenchymal tumors beyond the FET genes.
    Tauziède-Espariat A; Pierron G; Guillemot D; Sievers P; Cazals-Hatem D; Faillot T; Roux A; Benzakoun J; Bockel S; Weinbreck N; Hasty L; Lechapt E; Chrétien F; Varlet P
    Acta Neuropathol Commun; 2021 Oct; 9(1):174. PubMed ID: 34715942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system.
    Gritsch S; Batchelor TT; Gonzalez Castro LN
    Cancer; 2022 Jan; 128(1):47-58. PubMed ID: 34633681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations.
    Koelsche C; Mynarek M; Schrimpf D; Bertero L; Serrano J; Sahm F; Reuss DE; Hou Y; Baumhoer D; Vokuhl C; Flucke U; Petersen I; Brück W; Rutkowski S; Zambrano SC; Garcia Leon JL; Diaz Coronado RY; Gessler M; Tirado OM; Mora J; Alonso J; Garcia Del Muro X; Esteller M; Sturm D; Ecker J; Milde T; Pfister SM; Korshunov A; Snuderl M; Mechtersheimer G; Schüller U; Jones DTW; von Deimling A
    Acta Neuropathol; 2018 Aug; 136(2):327-337. PubMed ID: 29881993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DICER1-associated central nervous system sarcoma in children: comprehensive clinicopathologic and genetic analysis of a newly described rare tumor.
    Kamihara J; Paulson V; Breen MA; Laetsch TW; Rakheja D; Shulman DS; Schoettler ML; Clinton CM; Ward A; Reidy D; Pinches RS; Weiser DA; Mullen EA; Schienda J; Meyers PA; DuBois SG; Nowak JA; Foulkes WD; Schultz KAP; Janeway KA; Vargas SO; Church AJ
    Mod Pathol; 2020 Oct; 33(10):1910-1921. PubMed ID: 32291395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system sarcoma with ATXN1::DUX4 fusion expands the concept of CIC-rearranged sarcoma.
    Satomi K; Ohno M; Kubo T; Honda-Kitahara M; Matsushita Y; Ichimura K; Narita Y; Ichikawa H; Yoshida A
    Genes Chromosomes Cancer; 2022 Nov; 61(11):683-688. PubMed ID: 35715887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some CNS sarcomas seen: A 22-year series.
    Kleinschmidt-DeMasters BK; Gilani A
    Clin Neuropathol; 2023; 42(2):54-65. PubMed ID: 36708209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
    Louis DN; Perry A; Reifenberger G; von Deimling A; Figarella-Branger D; Cavenee WK; Ohgaki H; Wiestler OD; Kleihues P; Ellison DW
    Acta Neuropathol; 2016 Jun; 131(6):803-20. PubMed ID: 27157931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All pineal tumors expressing germ cell tumor markers are not necessarily germ cell tumors: histopathological and molecular study of a midline primary intracranial sarcoma DICER1-mutant.
    Wolf T; Coca AH; Weingertner N; Chenard MP; Meurgey A; Reita D; Pencreach E; Varlet P; Entz-Werlé N; Lhermitte B
    Virchows Arch; 2023 Feb; 482(2):431-435. PubMed ID: 36307659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An extracranial CNS presentation of the emerging "intracranial" mesenchymal tumor, FET: CREB-fusion positive.
    Tauziède-Espariat A; Pierron G; Guillemot D; Benevello C; Pallud J; Benzakoun J; Hasty L; Métais A; Chrétien F; Varlet P
    Brain Tumor Pathol; 2023 Jan; 40(1):35-39. PubMed ID: 36107277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The 2021 WHO classification of tumours of the central nervous system].
    Figarella-Branger D; Appay R; Metais A; Tauziède-Espariat A; Colin C; Rousseau A; Varlet P
    Ann Pathol; 2022 Oct; 42(5):367-382. PubMed ID: 34865882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB-fused broadening the spectrum of tumor entities in comparison with their soft tissue counterparts.
    Tauziède-Espariat A; Sievers P; Larousserie F; Benzakoun J; Guillemot D; Pierron G; Duchesne M; Uro-Coste E; Roux A; Vasiljevic A; Fenouil T; Meyronet D; Mokhtari K; Polivka M; Rousseau A; Bost-Bezeaud F; Akoury S; Pallud J; Benevello C; Hasty L; Gareton A; Lechapt E; Chrétien F; Blauwblomme T; Beccaria K; Puget S; Sahm F; Varlet P;
    Brain Pathol; 2022 Jan; 32(1):e13010. PubMed ID: 34314078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.